For the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

The ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...

ChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

Bain Capital is nearing a deal to buy a significant stake in IndusInd General Insurance. This acquisition could value the insurer at over s...

Private equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...

Private equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...

We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...

Luxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...

Fredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify....

Sugar is one of the oldest distressed sectors in India. For decades it has swung between glut and shortage, carried heavy debt, was depende...

The government is planning an expanded Production-Linked Incentive Scheme for the food processing sector. Consultations were held with indu...

Chocolate is a versatile ingredient celebrated for its intricate taste and diverse forms. It's integrated into an array of products, from b...

"At present, India does not have any kind of regulatory guidelines for the approval or monitoring of the products under this segment."

The Indian nutraceuticals market is divided into functional food and beverages (68 per cent) and dietary supplements (32 per cent).

The Indian nutraceutical market valued at $ 1,480 million in 2011 could grow to $ 2,731 million in 2016, a report said today.